Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Walter

Showing results (1131-1140 of 1,147) with videos related to

Pageof 115
Sort By:
Plos Medicine|June 29, 2016
Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical TrialsBenjamin Kasenda, Erik von Elm, John J You, et al.
The Journal of Pediatrics|April 15, 2017
Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort StudyStefan Schandelmaier, Yuki Tomonaga, Dirk Bassler, et al.
Nature Medicine|May 13, 2020
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titersPrabhu S Arunachalam, Tysheena P Charles, Vineet Joag, et al.
Critical Care Medicine|October 16, 2015
Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort StudyStefan Schandelmaier, Erik von Elm, John J You, et al.
JAMA Oncology|April 7, 2017
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed PreventionBirke Bausch, Francesca Schiavi, Ying Ni, et al.
Annals of Surgery|July 1, 2014
Completion and Publication Rates of Randomized Controlled Trials in Surgery: An Empirical StudyRachel Rosenthal, Benjamin Kasenda, Salome Dell-Kuster, et al.
The Journal of Allergy and Clinical Immunology|September 11, 2021
Immunologic resilience and COVID-19 survival advantageGrace C Lee, Marcos I Restrepo, Nathan Harper, et al.
Human Mutation|October 28, 2010
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10Karin Frank-Raue, Lisa A Rybicki, Zoran Erlic, et al.
Chemical Biology & Drug Design|June 22, 2007
From bacterial genomes to novel antibacterial agents: discovery, characterization, and antibacterial activity of compounds that bind to HI0065 (YjeE) from Haemophilus influenzaeClaude G Lerner, Philip J Hajduk, Rolf Wagner, et al.
American Journal of Human Genetics|April 16, 2021
A form of muscular dystrophy associated with pathogenic variants in JAG2Sandra Coppens, Alison M Barnard, Sanna Puusepp, et al.
Pageof 115

Showing results (1131-1140 of 1,147) with videos related to

Sort By:
Pageof 115
Plos Medicine|June 29, 2016
Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical TrialsBenjamin Kasenda, Erik von Elm, John J You, et al.
The Journal of Pediatrics|April 15, 2017
Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort StudyStefan Schandelmaier, Yuki Tomonaga, Dirk Bassler, et al.
Nature Medicine|May 13, 2020
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titersPrabhu S Arunachalam, Tysheena P Charles, Vineet Joag, et al.
Critical Care Medicine|October 16, 2015
Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort StudyStefan Schandelmaier, Erik von Elm, John J You, et al.
JAMA Oncology|April 7, 2017
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed PreventionBirke Bausch, Francesca Schiavi, Ying Ni, et al.
Annals of Surgery|July 1, 2014
Completion and Publication Rates of Randomized Controlled Trials in Surgery: An Empirical StudyRachel Rosenthal, Benjamin Kasenda, Salome Dell-Kuster, et al.
The Journal of Allergy and Clinical Immunology|September 11, 2021
Immunologic resilience and COVID-19 survival advantageGrace C Lee, Marcos I Restrepo, Nathan Harper, et al.
Human Mutation|October 28, 2010
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10Karin Frank-Raue, Lisa A Rybicki, Zoran Erlic, et al.
Chemical Biology & Drug Design|June 22, 2007
From bacterial genomes to novel antibacterial agents: discovery, characterization, and antibacterial activity of compounds that bind to HI0065 (YjeE) from Haemophilus influenzaeClaude G Lerner, Philip J Hajduk, Rolf Wagner, et al.
American Journal of Human Genetics|April 16, 2021
A form of muscular dystrophy associated with pathogenic variants in JAG2Sandra Coppens, Alison M Barnard, Sanna Puusepp, et al.
Pageof 115